Life Seal Vascular Awarded $1.25M NSF SBIR Phase II Grant to Advance Cygnum™ Device Toward FDA Clinical Trials
IRVINE, CA, UNITED STATES, August 6, 2026 /EINPresswire.com/ -- Life Seal Vascular, Inc. (LSV), a medical technology company developing innovative sealing solutions for endovascular aortic repair, has been awarded prestigious $1.25 million Phase …